Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Standardized Chemical Allergen [EPC]
Gelsemium Sempervirens Whole is a non-standardized plant allergenic extract primarily utilized in clinical immunology for the diagnosis and treatment of hypersensitivity to yellow jasmine. It belongs to the class of Standardized and Non-Standardized Plant Allergenic Extracts.
Name
Gelsemium Sempervirens Whole
Raw Name
GELSEMIUM SEMPERVIRENS WHOLE
Category
Standardized Chemical Allergen [EPC]
Drug Count
8
Variant Count
10
Last Verified
February 17, 2026
About Gelsemium Sempervirens Whole
Gelsemium Sempervirens Whole is a non-standardized plant allergenic extract primarily utilized in clinical immunology for the diagnosis and treatment of hypersensitivity to yellow jasmine. It belongs to the class of Standardized and Non-Standardized Plant Allergenic Extracts.
Detailed information about Gelsemium Sempervirens Whole
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Gelsemium Sempervirens Whole.
Gelsemium Sempervirens Whole, derived from the plant commonly known as Yellow Jasmine or Carolina Jessamine, is a complex biological product primarily utilized within the field of clinical immunology and allergy. In the context of modern medicine, it is classified as a Non-Standardized Plant Allergenic Extract [EPC]. This pharmaceutical preparation is created by extracting the proteinaceous and chemical components of the entire Gelsemium sempervirens plant to be used in diagnostic procedures, such as skin prick testing, or in therapeutic regimens, such as allergen immunotherapy (allergy shots).
Historically, the Gelsemium plant has been known for its potent alkaloids, including gelsemine and gelsemitine, which possess significant neurotoxic properties. However, in the standardized clinical setting, the 'Whole' extract is processed to serve as a tool for identifying patients who have developed IgE-mediated hypersensitivity (allergic reactions) to the plant's pollen or organic matter. According to the FDA regulatory framework, allergenic extracts like Gelsemium Sempervirens Whole are biological products. Unlike highly purified synthetic drugs, these extracts contain a wide array of naturally occurring proteins and polysaccharides that are essential for eliciting an immune response during diagnostic testing.
Your healthcare provider may utilize Gelsemium Sempervirens Whole if you exhibit symptoms of seasonal or perennial rhinitis (hay fever), conjunctivitis, or allergic asthma that appears to be triggered by environmental exposure to the yellow jasmine plant. It is important to note that while the plant itself is toxic if ingested, the clinical extract is prepared under strict laboratory conditions to ensure it is suitable for percutaneous (skin-surface) or intradermal (into the skin) administration by a trained allergist.
The mechanism of action for Gelsemium Sempervirens Whole depends entirely on its application. When used for diagnostic purposes, the extract works by introducing specific allergens directly to the mast cells (immune cells) located in the skin. If a patient is sensitized to Gelsemium, their immune system has already produced specific Immunoglobulin E (IgE) antibodies against the plant's proteins. These IgE antibodies are 'primed' on the surface of mast cells. Upon contact with the Gelsemium extract during a skin test, the allergens cross-link the IgE antibodies, triggering the mast cell to degranulate. This degranulation releases histamine and other inflammatory mediators, resulting in a localized 'wheal and flare' reaction (a raised bump surrounded by redness). This reaction allows the clinician to visually confirm the presence of an allergy.
In a therapeutic context, such as allergen immunotherapy, the mechanism is more complex and involves the induction of immune tolerance. By administering gradually increasing doses of Gelsemium Sempervirens Whole over a long period, the healthcare provider aims to shift the patient's immune response. This typically involves a decrease in IgE production, an increase in IgG4 (blocking antibodies), and the modulation of T-cell responses. Over time, this reduces the severity of symptoms when the patient is naturally exposed to the plant in the environment.
Because Gelsemium Sempervirens Whole is an allergenic extract administered locally (percutaneously or intradermally), its pharmacokinetic profile differs significantly from oral or intravenous medications.
Gelsemium Sempervirens Whole is primarily indicated for:
Gelsemium Sempervirens Whole is typically available in the following forms:
> Important: Only your healthcare provider can determine if Gelsemium Sempervirens Whole is right for your specific condition. Diagnostic testing and immunotherapy must always be performed under the supervision of a physician prepared to treat anaphylaxis.
Dosage for Gelsemium Sempervirens Whole is highly individualized and is not measured in milligrams like standard medications. Instead, it is measured in weight/volume (w/v) ratios or Protein Nitrogen Units (PNU).
Pediatric dosing follows the same principles as adult dosing, though healthcare providers often exercise extreme caution. Children as young as 5 years old may undergo testing and immunotherapy. The volume of the injection remains similar to adult doses, but the starting concentration may be lower depending on the child's sensitivity level and history of asthma. Gelsemium Sempervirens Whole is generally not recommended for children under the age of 5 due to the difficulty of monitoring for systemic reactions and the lower likelihood of established sensitization.
No specific dosage adjustments are required for patients with renal impairment, as the clearance of allergenic proteins is not primarily dependent on the kidneys. However, the patient's overall health must be stable before administration.
No dosage adjustments are established for hepatic impairment. The metabolic breakdown of the extract occurs via cellular pathways rather than hepatic enzyme systems.
Elderly patients may have reduced skin reactivity, which can lead to false-negative results during diagnostic testing. Furthermore, the presence of co-morbidities such as cardiovascular disease may increase the risk if a systemic reaction occurs. Healthcare providers will carefully evaluate the risk-benefit ratio in patients over 65.
This medication is NEVER for self-administration. It must be administered by a healthcare professional in a clinical setting equipped with emergency resuscitation equipment.
In immunotherapy, consistency is vital. If you miss a scheduled injection:
An 'overdose' in the context of Gelsemium Sempervirens Whole refers to the administration of a dose that exceeds the patient's current tolerance level. Signs of overdose (systemic reaction) include:
In the event of an overdose, emergency administration of epinephrine is the primary treatment. Healthcare providers will follow standard anaphylaxis protocols.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance.
Side effects are categorized into local reactions and systemic reactions. Local reactions are very common and are often expected as part of the diagnostic process.
> Warning: Stop taking Gelsemium Sempervirens Whole and call your doctor immediately if you experience any of these symptoms of anaphylaxis.
There are no known long-term systemic side effects associated with the proper clinical use of Gelsemium Sempervirens Whole. Unlike corticosteroids or other immunosuppressants, allergenic extracts do not cause organ damage or metabolic changes over time. The primary risk remains the potential for an acute allergic reaction during each administration.
While Gelsemium Sempervirens Whole may not carry a specific branded black box warning in all jurisdictions, the FDA requires a general boxed warning for all potent allergenic extracts.
Summary of Warning: Allergenic extracts can cause severe life-threatening systemic reactions, including anaphylaxis. They should only be administered by clinicians who are experienced in the use of allergenic extracts and are prepared to manage emergencies. Patients with unstable or severe asthma are at a significantly higher risk for fatal reactions. Always monitor the patient for at least 30 minutes post-injection.
Report any unusual symptoms to your healthcare provider.
Gelsemium Sempervirens Whole is a potent biological substance. It is only intended for use in patients with a documented clinical history of allergy to the plant. It is not a general-purpose medication and should never be used without professional supervision.
No FDA black box warnings are specific solely to the Gelsemium species; however, the Allergenic Extract Class Warning applies. This warning emphasizes that these products can cause anaphylaxis and must be administered in a setting where epinephrine and airway management tools are immediately available. Fatalities have occurred when injections were given to patients with poorly controlled asthma or during periods of acute respiratory infection.
Unlike many drugs, Gelsemium Sempervirens Whole does not require routine blood counts or liver function tests. Instead, monitoring is clinical:
Generally, Gelsemium Sempervirens Whole does not affect the ability to drive. However, if you experience a vasovagal reaction (fainting) or a systemic allergic reaction, you should not drive until you have fully recovered and been cleared by a medical professional.
Alcohol consumption should be avoided on the day of an immunotherapy injection. Alcohol can increase blood flow to the skin and potentially accelerate the absorption of the allergen, increasing the risk of a systemic reaction. Additionally, alcohol can mask the early symptoms of an allergic reaction.
Immunotherapy is typically a 3-to-5-year commitment. Stopping suddenly will not cause 'withdrawal' in the traditional sense, but it will result in the loss of the immune tolerance built up during treatment. If you stop for several months and wish to restart, you cannot return to your previous dose; you must start again at a lower, safer concentration.
> Important: Discuss all your medical conditions with your healthcare provider before starting Gelsemium Sempervirens Whole.
There are no specific food interactions with Gelsemium Sempervirens Whole. However, patients should avoid heavy meals or vigorous exercise immediately before and after an injection, as increased body temperature and metabolic rate can alter the absorption of the allergen.
Gelsemium Sempervirens Whole does not typically interfere with standard laboratory blood tests. However, it will directly affect:
For each major interaction, the mechanism usually involves the autonomic nervous system's ability to respond to inflammatory mediators or the pharmacological blockade of emergency treatments. Management always involves a thorough pre-treatment screening of the patient's current medication list.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking.
Patients allergic to Gelsemium sempervirens may show cross-reactivity with other members of the Gelsemiaceae or Loganiaceae families. While not common in standard allergy panels, clinicians should be aware of potential sensitivities to related botanical species. There is no known cross-sensitivity with common food items (oral allergy syndrome) specifically linked to Gelsemium.
> Important: Your healthcare provider will evaluate your complete medical history before prescribing Gelsemium Sempervirens Whole.
FDA Pregnancy Category C. There are no adequate and well-controlled studies of Gelsemium Sempervirens Whole in pregnant women. Animal reproduction studies have not been conducted. The primary concern is not the extract itself, but the potential for a systemic allergic reaction in the mother. Anaphylaxis can lead to maternal hypotension, which causes a sudden decrease in placental blood flow and fetal oxygen deprivation (hypoxia). Consequently, healthcare providers usually do not initiate new immunotherapy or perform skin testing during pregnancy. If a patient is already on a stable maintenance dose and is tolerating it well, the provider may choose to continue the same dose without further increases.
It is not known whether the allergenic components of Gelsemium Sempervirens Whole are excreted in human milk. Because these are large proteins that are typically broken down at the site of injection, it is highly unlikely that significant amounts reach the breast milk. Breastfeeding is generally considered safe for women receiving immunotherapy, provided they have not had recent systemic reactions.
Safety and effectiveness in children under the age of 5 have not been established. In children 5 and older, Gelsemium Sempervirens Whole is used similarly to adults. However, clinicians must be extra vigilant, as young children may not be able to articulate the early symptoms of a systemic reaction (such as an itchy throat or a feeling of 'doom'). Growth effects have not been observed with the use of allergenic extracts.
Clinical studies of Gelsemium Sempervirens Whole did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. In general, dose selection for an elderly patient should be cautious, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy (especially beta-blockers for hypertension).
No specific studies have been conducted in patients with renal impairment. However, because the proteins are metabolized by local cellular processes and not excreted intact by the kidneys, renal failure is not a contraindication. The patient's overall hemodynamic stability is the more important factor.
There is no evidence that hepatic impairment alters the safety or efficacy of Gelsemium Sempervirens Whole. The extract does not undergo significant hepatic metabolism.
> Important: Special populations require individualized medical assessment.
Gelsemium Sempervirens Whole acts as an exogenous antigen. In the diagnostic setting, it functions by binding to specific IgE antibodies on the surface of cutaneous mast cells. This binding causes the cross-linking of the high-affinity IgE receptor (FcεRI), leading to the release of pre-formed mediators like histamine and the synthesis of newly formed mediators like leukotrienes and prostaglandins.
In the therapeutic setting, the extract modulates the immune system. It induces the production of 'blocking antibodies' (IgG4) which compete with IgE for the allergen binding sites. It also promotes a shift from a Th2-dominated immune response (which promotes allergy) to a Th1-dominated response or the induction of Regulatory T-cells (Tregs) that secrete IL-10 and TGF-beta, which suppress allergic inflammation.
| Parameter | Value |
|---|---|
| Bioavailability | Negligible (Local administration) |
| Protein Binding | N/A (Biological proteins) |
| Half-life | Variable (Local degradation) |
| Tmax | 15-20 minutes (for local reaction) |
| Metabolism | Proteolysis by macrophages/enzymes |
| Excretion | Lymphatic clearance |
Gelsemium Sempervirens Whole is a non-standardized biological extract. It contains a mixture of:
Gelsemium Sempervirens Whole is classified as a Non-Standardized Plant Allergenic Extract. It belongs to the broader therapeutic category of Allergenic Extracts used for diagnosis and immunotherapy. Related medications include extracts for Ragweed, Timothy Grass, and Oak pollen.
Common questions about Gelsemium Sempervirens Whole
Gelsemium Sempervirens Whole is primarily used by allergists to diagnose and treat allergies to the yellow jasmine plant. In the diagnostic phase, it is applied to the skin to see if a 'wheal and flare' reaction occurs, confirming an allergy. In the therapeutic phase, it is used in 'allergy shots' (immunotherapy) to help the body build a tolerance to the plant. This treatment is intended for patients who suffer from hay fever or allergic asthma triggered by this specific plant. It is not used for general pain or anxiety, unlike some homeopathic preparations of the same plant.
The most common side effects are local reactions at the site of the skin test or injection, including redness, itching, and a raised bump (wheal). These symptoms are usually mild and disappear within a few hours. Some patients may also experience a 'large local reaction' where the swelling covers a bigger area of the arm. While these are common, they are generally not dangerous. However, they must be reported to your doctor so they can adjust your next dose of immunotherapy if necessary.
It is strongly recommended that you avoid alcohol on the days you receive an injection of Gelsemium Sempervirens Whole. Alcohol can dilate your blood vessels and increase blood flow, which might cause the allergen to be absorbed into your system more quickly, increasing the risk of a serious allergic reaction. Furthermore, alcohol can make you less aware of the early warning signs of anaphylaxis. For your safety, wait at least 24 hours after your injection before consuming alcoholic beverages. Always discuss your lifestyle habits with your allergist.
Gelsemium Sempervirens Whole is generally not started during pregnancy because of the risk of anaphylaxis. If a mother has a severe allergic reaction, it can cause a drop in blood pressure that reduces oxygen to the baby, which is very dangerous. However, if a woman is already on a stable maintenance dose of allergy shots and becomes pregnant, her doctor may decide to continue the treatment at that same dose. Skin testing for allergies is almost always postponed until after delivery. Always inform your doctor immediately if you become pregnant while receiving this treatment.
For diagnostic purposes, Gelsemium Sempervirens Whole works very quickly, with results appearing on the skin within 15 to 20 minutes. For therapeutic immunotherapy, the process is much slower and requires patience. Most patients begin to feel a reduction in their allergy symptoms after 3 to 6 months of regular injections. The full benefit of the treatment is typically reached after one year of maintenance doses. A standard course of treatment usually lasts 3 to 5 years to provide long-lasting relief after the shots are stopped.
Yes, you can stop Gelsemium Sempervirens Whole injections at any time without experiencing physical withdrawal symptoms like you might with other medications. However, if you stop before completing the recommended 3-to-5-year course, your allergy symptoms are likely to return. If you miss several doses and then decide to restart, you cannot go back to your previous high dose because your body may have lost its tolerance, making a reaction more likely. You should always talk to your allergist before deciding to discontinue your immunotherapy program.
If you miss an appointment for your Gelsemium Sempervirens Whole injection, contact your allergist's office as soon as possible to reschedule. If you only miss a few days, you can usually continue with your planned schedule. However, if you miss several weeks, your doctor will likely need to reduce your dose for the next injection to ensure you don't have a reaction. Consistency is the key to successful immunotherapy, so try to keep your appointments as regular as possible. Never attempt to 'double up' on doses to make up for a missed one.
There is no clinical evidence to suggest that Gelsemium Sempervirens Whole causes weight gain. Unlike some other medications used for allergies, such as oral corticosteroids (like prednisone), allergenic extracts do not affect your metabolism, appetite, or fat distribution. The extract consists of proteins and plant matter that act locally on your immune system. If you experience weight changes while on this treatment, it is likely due to other factors or medications, and you should discuss this with your primary care physician.
Gelsemium Sempervirens Whole can be taken with many common medications, but there are some critical exceptions. You must avoid beta-blockers (often used for blood pressure or heart issues) because they make allergic reactions harder to treat. You should also tell your doctor if you are taking antidepressants like MAOIs or TCAs. Antihistamines won't cause a dangerous interaction, but they will block the results of a skin test, so they must be stopped a few days before testing. Always provide your allergist with a complete list of all drugs and supplements you use.
Gelsemium Sempervirens Whole is a biological product, and the concept of 'generic' works differently than it does for chemical pills. While there are different manufacturers of Gelsemium allergenic extracts, they are not considered interchangeable. Each manufacturer has its own proprietary method for creating the extract, which means the potency can vary between brands. If your doctor starts your treatment with one manufacturer's extract, they will generally try to keep you on that same brand for the duration of your treatment to ensure safety and consistency.